Skip to main content
. 2019 Nov 8;98(3):188–197K. doi: 10.2471/BLT.19.231522

Fig. 4.

Relative risk of a sustained virological response to hepatitis C treatment by brand-name versus generic direct-acting agents, systematic review and meta-analysis, 2019

CI: confidence interval; RR: relative risk.

Fig. 4